⌘K

Login Start Free

Home/Filings/4/0001104659-23-022389

4//SEC Filing

Ni Fang 4

Accession 0001104659-23-022389

CIK 0001701541other

View on SEC.gov Company Profile

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 4:11 PM ET

Size

5.6 KB

Accession

0001104659-23-022389

Insider Transaction Report

Form 4

Period: 2023-02-13

Black Diamond Therapeutics, Inc.BDTX

See Remarks

Transactions

Award
Stock Option (Right to Buy)
2023-02-13+400,000→ 400,000 total
Exercise: $2.92Exp: 2033-02-12→ Common Stock (400,000 underlying)

Footnotes (1)

[F1]25% of the shares subject to this option shall vest and become exercisable on February 13, 2024, with the remainder vesting in 36 equal monthly installments thereafter.

Documents

1 file

4
tm236831-5_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Black Diamond Therapeutics, Inc.

CIK 0001701541

Entity typeother

Related Parties

1

filerCIK 0001895910

Filing Metadata

Form type: 4
Filed: Feb 14, 7:00 PM ET
Accepted: Feb 15, 4:11 PM ET
Size: 5.6 KB

View on SEC.gov